Table:
begin	end	state
1	19	cytoplasmic
20	38	transmembrane
39	58	non-cytoplasmic
59	80	transmembrane
81	86	cytoplasmic
87	107	transmembrane
108	112	non-cytoplasmic
113	137	transmembrane
138	155	cytoplasmic
156	176	transmembrane
177	203	non-cytoplasmic
204	224	transmembrane
225	254	cytoplasmic
255	275	transmembrane
276	287	non-cytoplasmic
288	309	transmembrane
310	317	cytoplasmic
318	338	transmembrane
339	341	non-cytoplasmic
342	362	transmembrane
363	373	cytoplasmic
374	396	transmembrane
397	401	non-cytoplasmic
402	421	transmembrane
422	444	cytoplasmic

Input:
>WP_091372717.1 NCBI__GCF_900105165.1:WP_091372717.1
MGALSQSRNEVWGFVPRRNLLSFSLVTMLFLIWGIPNNMNDILIKQFMKSFELSRTQAGL
IQSAFYMGYFFLAVPSGLIMKKYSYKVGLIAGLLLFALGCCLFWPAAVAGKYGLFLFALF
VIASGLTFLETGANIFIVELGESQSAERRLNFSQAFNPIGAVLGVLIGTIFILSGIEHDP
LKITAMKLSGEYQHYLQQETMRVVTPYLVLAAFAVLWSIFLMFTKFPKGRDELKEENAVK
ANSRELLKYPHFYKGVISQFFYCGAQTCTWSFFIQYVQDFTGQPEKIAGYFLTGTLVAFG
VGRFSATYIMRYVSPGKLMGIYGFVNVGLVAIAILIPGFIGVWAIFFTSFFMSLMYPTNF
ALSIRNLGNNAKIGGSIMVMAIVGGAFFPPVMGLIAESTKSMAIAMVIPLICYLYIAYYA
LRGSKIPGELIEEVAASAKILPTH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server